🔎 Trials Near Me

Akèy › Distrofi myotonik › Virginia

Etid klinik pou Distrofi myotonik nan Virginia

8 etid pou Distrofi myotonik ap chèche patisipan nan sit nan Virginia.

Vil nan Virginia

Tèks ofisyèl etid la (Anglè)

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

  • Virginia Commonwealth University - Biotech One, Richmond
Ap rekriteFaz 3
Laj 16 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07486934

A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1

  • Virginia Commonwealth University Medical Center- Site Number : 8400006, Richmond
Ap rekriteFaz 1/2
Laj 10 a 55 · Tout sèks · Mizajou Sep 21, 2026 · NCT06844214

Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension

  • Virginia Commonwealth University, Richmond
Ap rekriteEtid obsèvasyon
Laj 18 a 70 · Tout sèks · Mizajou Sep 4, 2026 · NCT07700225

Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension

  • Virginia Commonwealth University, Richmond
Ap rekriteEtid obsèvasyon
Laj 3 a 17 · Tout sèks · Mizajou Aug 11, 2026 · NCT06747884

Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

  • Virginia Commonwealth University, Richmond
Ap rekriteEtid obsèvasyon
Laj 18 a 70 · Tout sèks · Mizajou Jun 10, 2026 · NCT03981575

DMCRN-02-001: Assessing Pediatric Endpoints in DM1

  • Virginia Commonwealth University, Richmond
Ap rekriteEtid obsèvasyon
59 Months · Tout sèks · Mizajou Jun 10, 2026 · NCT05224778

Study of ATX-01 in Participants With DM1

  • Virginia Commonwealth University, Richmond
Ap rekriteFaz 1/2
Laj 18 a 64 · Tout sèks · Mizajou Feb 10, 2026 · NCT06300307

Long-Term Development of Muscular Dystrophy Outcome Assessments

  • Virginia Commonwealth University, Richmond
Ap rekriteEtid obsèvasyon
Laj 6 a 50 · Tout sèks · Mizajou Nov 18, 2025 · NCT05989620

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.